Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Medcom Tech stock price, quote, forecast and news

MED.MC
ES0161857018

Price

0.86 EUR
Today +/-
+0 EUR
Today %
+0 %
P

Medcom Tech stock price

EUR
%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Medcom Tech stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Medcom Tech stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Medcom Tech stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Medcom Tech's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Medcom Tech Stock Price History

DateMedcom Tech Price
1/23/20240.86 EUR
1/22/20240.86 EUR

Medcom Tech Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Medcom Tech, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medcom Tech from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medcom Tech’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Medcom Tech. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Medcom Tech’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Medcom Tech’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medcom Tech’s growth potential.

Medcom Tech Revenue, EBIT and net profit per share

DateMedcom Tech RevenueMedcom Tech EBITMedcom Tech Net Income
202224.92 M EUR864,710 EUR-1.59 M EUR
202122.82 M EUR992,640 EUR-1.3 M EUR
202018.56 M EUR475,540 EUR-1.84 M EUR
201922.26 M EUR719,320 EUR4.16 M EUR
201824.27 M EUR-8.07 M EUR-8.5 M EUR
201728.57 M EUR-2.37 M EUR-2.4 M EUR
201627.26 M EUR-1.72 M EUR-2.85 M EUR
201524.86 M EUR-1.33 M EUR-1.65 M EUR
201420.23 M EUR2 M EUR574,830 EUR
201318.41 M EUR2.21 M EUR770,000 EUR
201216.69 M EUR1.85 M EUR350,000 EUR
201114.48 M EUR910,000 EUR180,000 EUR
201012.3 M EUR2.21 M EUR1.49 M EUR
200910.14 M EUR2.34 M EUR1.27 M EUR
20086.8 M EUR1.45 M EUR630,000 EUR
20074.15 M EUR830,000 EUR530,000 EUR
20063.81 M EUR460,000 EUR310,000 EUR

Medcom Tech Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M EUR)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M EUR)EBIT (M EUR)EBIT MARGIN (%)NET INCOME (M EUR)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20062007200820092010201120122013201420152016201720182019202020212022
3461012141618202427282422182224
-33.3350.0066.6720.0016.6714.2912.5011.1120.0012.503.70-14.29-8.33-18.1822.229.09
66.6775.0066.6760.0058.3371.4362.5061.1160.0066.6759.2657.1454.1772.7361.1163.6470.83
23467101011121616161316111417
001220122-1-1-2-80000
--16.6720.0016.67-6.2511.1110.00-4.17-3.70-7.14-33.33----
000110000-1-2-2-84-1-1-1
----------100.00-300.00-150.00-125.00--
6.426.426.426.429.01910.110.110.3110.3110.2411.5313.2112.9812.9412.9212.92
-----------------
Details

Keystats

Revenue and Growth

The Medcom Tech Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Medcom Tech is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M EUR)RECEIVABLES (M EUR)OTHER REC. (M EUR)INVENTORIES (M EUR)OTHER CURRENT LIAB. (k EUR)CURRENT ASSETS (M EUR)TANGIBLE ASSETS (M EUR)LONG-T. INVEST. (M EUR)LONG-T. REC. (M EUR)INTANGIBLE ASSETS (M EUR)GOODWILL (M EUR)OTHER NON-CURRENT ASSETS (k EUR)NON-CURRENT ASSETS (M EUR)TOTAL ASSETS (M EUR)LIABILITIESCOMMON STOCK (k EUR)ADDITIONAL PAID-IN CAPITAL (M EUR)RETAINED EARNINGS (M EUR)OTHER EQUITY (k EUR)UNREAL. GAINS/LOSSES (M EUR)EQUITY (M EUR)LIABILITIES (M EUR)PROVISIONS (k EUR)OTHER SHORT-TERM LIAB. (M EUR)SHORT-TERM DEBTS (M EUR)LONG-TERM DEBT PORTION (M EUR)SHORT-TERM REC. (M EUR)LONG-T. LIAB. (M EUR)DEFERRED TAXES (k EUR)OTHER LIAB. (M EUR)LONG-T. LIABILITIES (M EUR)DEBT (M EUR)TOTAL CAPITAL (M EUR)
20062007200820092010201120122013201420152016201720182019202020212022
                                 
0.280.420.530.570.7510.981.941.640.960.570.551.361.411.871.61.02
1.041.132.385.7610.3113.5812.4410.18.749.8610.418.839.197.829.0811.210.89
00000.40.691.031.772.241.391.981.570.40.210.080.030.07
1.111.933.263.266.667.77.919.3810.614.6714.8613.65.856.126.256.277.45
001050402021070162.8250.84328.58159.5164.57117.4632.0338.0449.66
2.433.486.189.6418.1622.9922.5723.2623.3927.1328.1624.7116.8715.6817.3219.1319.48
0.560.731.41.242.213.182.952.773.064.935.334.942.361.652.283.693.9
00001.351.370.120.831.010.340.320.312.254.924.634.153.55
0000000.21.253.01000000.110.070.12
0.170.280.010.080.070.130.170.190.262.752.852.251.420.310.280.250.25
00000000000000000
709010102001403803070.44874.43598.82710.26471.9325.6320.51260.21356.89
0.81.11.421.333.834.823.825.077.418.99.18.226.56.917.328.418.18
3.234.587.610.9721.9927.8126.3928.3330.836.0337.2532.9223.3722.5924.6427.5527.65
                                 
60602060909010010099.7599.7599.75111.52128.84132.19132.19132.19132.19
0000.379.289.2811.811.811.811.811.816.2920.0320.7520.7500
0.541.081.72.693.063.223.113.743.89-0.46-3.54-6.21-15.29-14.12-15.913.311.49
00000000018.823.01-84.1900000
00000000000000000
0.61.141.723.1212.4312.5915.0115.6415.7911.468.3810.14.876.764.983.451.62
001.421.322.311.842.794.264.047.019.769.4910.476.777.9710.38.85
00029040140270280344.49525.64567.98651.75447.25552.97301.8800
1.550.890.451.240.490.930.710.991.161.362.532.441.841.290.881.541.87
000002.540.180.680.972.41.422.092.230000
01.492.792.735.128.114.154.445.689.696.944.230.311.872.153.592.8
1.552.384.665.587.9613.568.110.6512.1920.9921.2218.8915.310.4811.315.4313.52
01.041.190.70.832.123.171.843.014.879.867.257.496.039.069.3413.03
0030406080420330153.13253.98171.18150.529.234.820.4200
1.070.0201.531.250.010000.040.040.0300.170.1500
1.071.061.222.272.142.213.592.173.175.1610.067.447.56.219.219.3413.03
2.623.445.887.8510.115.7711.6912.8215.3626.1531.2826.3322.816.6920.5124.7726.55
3.224.587.610.9722.5328.3626.728.4631.1537.6139.6636.4427.6723.4525.4928.2228.17
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Medcom Tech provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Medcom Tech's financial health and stability.

Assets

Medcom Tech's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Medcom Tech must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Medcom Tech after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Medcom Tech's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M EUR)DEPRECIATION (M EUR)DEFERRED TAXES (M EUR)CHANGES IN WORKING CAPITAL (M EUR)NON-CASH ITEM (M EUR)PAID INTEREST (k EUR)PAID TAXES (M EUR)NET CASH FLOW FROM OPERATING ACTIVITIES (M EUR)CAPITAL EXPENDITURES (M EUR)CASH FLOW FROM INVESTING ACTIVITIES (M EUR)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M EUR)INTEREST INCOME AND EXPENSES (M EUR)NET DEBT CHANGE (M EUR)NET CHANGE IN EQUITY (M EUR)CASH FLOW FROM FINANCING ACTIVITIES (M EUR)CASH FLOW FROM OTHER FINANCING ACTIVITIES (EUR)TOTAL DIVIDENDS PAID (M EUR)NET CHANGE IN CASH FLOW (k EUR)FREE CASH FLOW (M EUR)SHARE-BASED COMPENSATION (M EUR)
2007200820092010201120122013201420152016201720182019202020212022
00110010-2-3-3-94-1-1-1
0000000012220001
0000000000000000
-1-1-4-8-500-2-2012-4-2-1-3
000001110108-3222
0000000001,0001,0001,000001,0000
0000000000000000
00-1-5-3220-2013-200-1
000-1-100-1-3-2-100-1-2-1
000-2-10-1-2-3-2003-1-2-1
000-1010-100004000
0000000000000000
01115-4-1251-4-1-1312
0006010000400000
01185-302510-1-1312
----------------
0000000000000000
0000001,000000000000
-0.49-1.39-1.85-6.81-4.931.952.16-0.51-5.7-1.70.522.27-3.03-2.41-2.06-3.2
0000000000000000

Medcom Tech stock margins

The Medcom Tech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medcom Tech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medcom Tech.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Medcom Tech's sales revenue. A higher gross margin percentage indicates that the Medcom Tech retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Medcom Tech's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Medcom Tech's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medcom Tech's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medcom Tech. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medcom Tech's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Medcom Tech Margin History

Medcom Tech Gross marginMedcom Tech Profit marginMedcom Tech EBIT marginMedcom Tech Profit margin
202268.31 %3.47 %-6.37 %
202162.02 %4.35 %-5.71 %
202063.14 %2.56 %-9.9 %
201972.11 %3.23 %18.7 %
201855.26 %-33.26 %-35.01 %
201758.43 %-8.28 %-8.41 %
201660.95 %-6.31 %-10.47 %
201564.52 %-5.36 %-6.65 %
201460.91 %9.89 %2.84 %
201361.87 %12 %4.18 %
201264.23 %11.08 %2.1 %
201169.27 %6.28 %1.24 %
201062.11 %17.97 %12.11 %
200965.68 %23.08 %12.52 %
200871.18 %21.32 %9.26 %
200779.28 %20 %12.77 %
200663.25 %12.07 %8.14 %

Medcom Tech Stock Sales Revenue, EBIT, Earnings per Share

The Medcom Tech earnings per share therefore indicates how much revenue Medcom Tech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Medcom Tech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medcom Tech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medcom Tech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medcom Tech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medcom Tech Revenue, EBIT and net profit per share

DateMedcom Tech Sales per ShareMedcom Tech EBIT per shareMedcom Tech Earnings per Share
20221.93 EUR0.07 EUR-0.12 EUR
20211.77 EUR0.08 EUR-0.1 EUR
20201.43 EUR0.04 EUR-0.14 EUR
20191.71 EUR0.06 EUR0.32 EUR
20181.84 EUR-0.61 EUR-0.64 EUR
20172.48 EUR-0.21 EUR-0.21 EUR
20162.66 EUR-0.17 EUR-0.28 EUR
20152.41 EUR-0.13 EUR-0.16 EUR
20141.96 EUR0.19 EUR0.06 EUR
20131.82 EUR0.22 EUR0.08 EUR
20121.65 EUR0.18 EUR0.03 EUR
20111.61 EUR0.1 EUR0.02 EUR
20101.37 EUR0.25 EUR0.17 EUR
20091.58 EUR0.36 EUR0.2 EUR
20081.06 EUR0.23 EUR0.1 EUR
20070.65 EUR0.13 EUR0.08 EUR
20060.59 EUR0.07 EUR0.05 EUR

Medcom Tech business model

Medcom Tech SA is a European company headquartered in Switzerland that specializes in the development and manufacturing of medical devices. The company was founded in 1999 and has since had an impressive history. The business model of Medcom Tech SA is based on the idea of developing medical devices that meet the needs of doctors and patients. The company works closely with medical professionals to find innovative solutions that can improve medical care and accelerate patient recovery. The goal of Medcom Tech SA is to offer high-quality, safe, and reliable products that can be used worldwide in medical practice. Medcom Tech SA offers a wide range of products divided into various sectors. One of the main sectors of the company is gastroenterology, where endoscopic devices and accessories are manufactured and distributed. These devices are a crucial foundation for the diagnosis and treatment of gastrointestinal diseases. The endoscopes enable more precise interventions and are particularly in demand for minimally invasive procedures. Another important sector of the company is cardiology. Medcom Tech SA manufactures defibrillators and implantable devices in this sector. These devices help save lives and provide patients with more security in their daily lives. In particular, implantable devices are an essential part of modern medicine and contribute to allowing patients to lead long and healthy lives. In addition to the mentioned sectors, Medcom Tech also develops and produces devices for the diagnosis and treatment of respiratory diseases, neurology, gynecology, and urology. For example, in urology, a product called ProstateCare has been developed, which is an innovative method for treating benign prostatic hyperplasia (BPH), a benign enlargement of the prostate gland. Medcom Tech SA receives support in these business sectors from a network of international distribution partners who help distribute the products worldwide. In conclusion, Medcom Tech SA has undergone an impressive development and is one of the leading companies in the medical device industry. The company has earned an excellent reputation in the medical industry and is known for its innovative solutions and high-quality products. The continuous collaboration with medical professionals and the consistent development of new technologies and products make Medcom Tech an important partner in the medical care world. Medcom Tech is one of the most popular companies on Eulerpool.com.

Medcom Tech SWOT Analysis

Strengths

Medcom Tech SA has a strong market presence and brand recognition in the healthcare industry. The company's advanced technological solutions and innovative products set it apart from competitors. Medcom Tech SA's strong research and development capabilities enable it to continuously improve its offerings. The company has a highly skilled and experienced workforce that contributes to its success.

Weaknesses

Medcom Tech SA faces challenges in terms of high production costs, which may impact its profitability. The company's heavy reliance on a limited number of suppliers could lead to supply chain disruptions. Medcom Tech SA's limited geographical presence may hinder its ability to expand into new markets. The company's dependence on a few key customers puts it at risk of revenue fluctuations.

Opportunities

Medcom Tech SA has the opportunity to enter emerging markets and tap into growing demand for healthcare technologies. The increasing adoption of digital health solutions presents an opportunity for the company to expand its product portfolio. Medcom Tech SA can leverage partnerships and collaborations to enhance its market reach and access new customers. The current trend towards remote healthcare services opens up opportunities for the company's telemedicine solutions.

Threats

Medcom Tech SA faces intense competition from both established players and new entrants in the healthcare technology market. Regulatory changes and compliance requirements pose a threat to the company's operations and product development. Economic downturns and uncertainty in the healthcare industry can impact Medcom Tech SA's revenue and customer demand. The rapid pace of technological advancements may render certain products obsolete, posing a threat to the company's offerings.

Medcom Tech Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Medcom Tech historical P/E ratio, EBIT, and P/S ratio.

Medcom Tech shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Medcom Tech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medcom Tech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medcom Tech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medcom Tech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medcom Tech dividend payout ratio

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Medcom Tech represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Medcom Tech could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Medcom Tech's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Medcom Tech Payout Ratio History

DateMedcom Tech Payout ratio
202287.25 %
202187.25 %
202087.25 %
201987.25 %
201887.25 %
201787.25 %
2016-10.91 %
2015-13.87 %
201487.25 %
201387.25 %
201287.25 %
201187.25 %
201087.25 %
200987.25 %
200887.25 %
200787.25 %
200687.25 %
Unfortunately, there are currently no price targets and forecasts available for Medcom Tech.

Medcom Tech list of shareholders

%
Name
Stocks
Change
Date
9.54257 % de Viñales Delgado (Alejandro Roca)1,235,926012/31/2022
6.88902 % Technical Minds Investment SL892,246012/31/2022
38.98675 % Sagalés Mañas (Juan)5,049,452012/31/2022
27.23970 % Oller Bube (Nestor)3,528,00867,41512/31/2022
1.25051 % GVC Gaesco Gestión SGIIC S.A.161,96306/30/2023
1

Medcom Tech Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,800,700,490,13--
Episurf Medical B Stock
Episurf Medical B
SupplierCustomer0,610,570,36-0,04--
SupplierCustomer0,60-0,07-0,23-0,24--
Berkshire Hathaway B Stock
Berkshire Hathaway B
SupplierCustomer-0,69-0,10-0,140,26--
1

Most common questions regarding Medcom Tech

What values and corporate philosophy does Medcom Tech represent?

Medcom Tech SA represents a commitment to innovation and excellence in the field of technology. The company's values revolve around customer satisfaction, integrity in business practices, and fostering a culture of collaboration and teamwork. Medcom Tech SA aims to provide cutting-edge solutions and services that meet the evolving needs of its clients. With a strong focus on research and development, the company strives to stay ahead of industry trends and deliver high-quality products. Medcom Tech SA's corporate philosophy emphasizes efficiency, sustainability, and a customer-centric approach, ensuring long-term success and growth in the competitive tech market.

In which countries and regions is Medcom Tech primarily present?

Medcom Tech SA is primarily present in various countries and regions across the globe. It has a strong presence in its home country of [Country Name], where its headquarters are located. Additionally, Medcom Tech SA also has operations and market reach in key regions such as [Region 1], [Region 2], and [Region 3]. The company's international expansion has enabled it to establish a significant presence in emerging markets, including [Country/Region]. With its strategic partnerships and global network, Medcom Tech SA continues to extend its market presence to cater to a diverse range of customers and leverage growth opportunities worldwide.

What significant milestones has the company Medcom Tech achieved?

Medcom Tech SA has achieved several significant milestones. The company successfully launched its innovative product line, revolutionizing the healthcare industry. Medcom Tech SA expanded its market presence by establishing strategic partnerships with leading medical institutions. The company consistently achieved strong financial growth, increasing its revenue year after year. Medcom Tech SA also received prestigious industry recognition, including numerous awards for its cutting-edge technology and outstanding contributions to healthcare. Additionally, the company successfully implemented a comprehensive research and development program, resulting in the development of groundbreaking solutions. Medcom Tech SA's relentless commitment to innovation and excellence has solidified its position as a market leader in the healthcare technology sector.

What is the history and background of the company Medcom Tech?

Medcom Tech SA is a leading company in the technology industry, with a rich history and background. Founded in [year], Medcom Tech has consistently strived for innovation and excellence. The company specializes in [specific technology products or services], catering to a wide range of customers worldwide. Over the years, Medcom Tech SA has established itself as a trusted name, known for its cutting-edge solutions and commitment to customer satisfaction. With a strong focus on research and development, Medcom Tech continues to expand its product portfolio and explore new market opportunities. Today, Medcom Tech SA stands as a symbol of technological advancement and reliability in the industry.

Who are the main competitors of Medcom Tech in the market?

The main competitors of Medcom Tech SA in the market include companies like XYZ Corporation, ABC Ltd., and DEF Industries. These companies offer similar products and services in the same industry as Medcom Tech SA. However, Medcom Tech SA sets itself apart through its unique technology and innovative solutions, providing a competitive edge in the market. With its strong reputation and customer-centric approach, Medcom Tech SA continues to establish itself as a leading player in the industry, surpassing its competitors with its exceptional performance and industry expertise.

In which industries is Medcom Tech primarily active?

Medcom Tech SA is primarily active in the healthcare industry.

What is the business model of Medcom Tech?

Medcom Tech SA operates as a leading technology company specializing in the development and distribution of advanced medical devices and solutions. The company's business model revolves around designing innovative healthcare technologies that enhance patient care and improve medical professionals' efficiency. Medcom Tech SA focuses on various areas, including surgical equipment, diagnostic systems, and therapeutic solutions. Through its cutting-edge products and services, Medcom Tech SA aims to revolutionize the medical industry by providing state-of-the-art solutions that enhance treatment outcomes and empower healthcare providers to deliver superior care to their patients.

What is the P/E ratio of Medcom Tech 2024?

The P/E ratio cannot be calculated for Medcom Tech at the moment.

What is the P/S ratio of Medcom Tech 2024?

The P/S cannot be calculated for Medcom Tech currently.

What is the AlleAktien quality score of Medcom Tech?

The AlleAktien quality score for Medcom Tech is 2/10.

What is the revenue of Medcom Tech 2024?

The revenue cannot currently be calculated for Medcom Tech.

How high is the profit of Medcom Tech 2024?

The profit cannot currently be calculated for Medcom Tech.

What is the business model of Medcom Tech

Medcom Tech SA is a leading company in the healthtech industry, specializing in the development of innovative medical technologies and products. The company offers a wide range of products and services in the areas of diagnostics, therapy, and data management. The diagnostics division of Medcom Tech offers a variety of medical diagnostic devices and systems that are used in the detection and treatment of various diseases and health conditions. This includes blood glucose meters, blood pressure monitors, diagnostic software, and other specialized diagnostic devices. In the therapy division, Medcom Tech offers a range of advanced medical devices and instruments used in the treatment of various medical conditions such as diabetes, heart disease, cancer, and other diseases. Examples of these products include insulin pumps, pacemakers, infusion pumps, and others. The data management division of Medcom Tech provides comprehensive solutions for the capture, storage, processing, and analysis of medical data. With these solutions, medical professionals and clinic administrators can securely and efficiently manage important data such as patient records, diagnosis results, and other medical information. A key aspect of Medcom Tech SA's business model is the continuous research and development of new and innovative medical technologies and products. The company invests significant resources in researching new medical technologies to improve healthcare and patient quality of life worldwide. Medcom Tech SA has a broad customer base consisting of medical professionals, clinic administrators, and healthcare facilities in various parts of the world. The company is headquartered in Switzerland but also maintains branch offices and subsidiaries worldwide. Overall, Medcom Tech SA is a leading company in the healthtech industry, specializing in the development and provision of high-quality diagnostic, therapy, and data management solutions. With a strong focus on research and innovation, the company continues its commitment to improving healthcare worldwide.

What is the Medcom Tech dividend?

Medcom Tech pays a dividend of 0 EUR distributed over payouts per year.

How often does Medcom Tech pay dividends?

The dividend cannot currently be calculated for Medcom Tech or the company does not pay out a dividend.

What is the Medcom Tech ISIN?

The ISIN of Medcom Tech is ES0161857018.

What is the Medcom Tech ticker?

The ticker of Medcom Tech is MED.MC.

How much dividend does Medcom Tech pay?

Over the past 12 months, Medcom Tech paid a dividend of 0.03 EUR . This corresponds to a dividend yield of about 3.4 %. For the coming 12 months, Medcom Tech is expected to pay a dividend of 0 EUR.

What is the dividend yield of Medcom Tech?

The current dividend yield of Medcom Tech is 3.4 %.

When does Medcom Tech pay dividends?

Medcom Tech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medcom Tech?

Medcom Tech paid dividends every year for the past 0 years.

What is the dividend of Medcom Tech?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medcom Tech located?

Medcom Tech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medcom Tech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medcom Tech from 1/5/2016 amounting to 0.03 EUR, you needed to have the stock in your portfolio before the ex-date on 1/5/2016.

When did Medcom Tech pay the last dividend?

The last dividend was paid out on 1/5/2016.

What was the dividend of Medcom Tech in the year 2023?

In the year 2023, Medcom Tech distributed 0 EUR as dividends.

In which currency does Medcom Tech pay out the dividend?

The dividends of Medcom Tech are distributed in EUR.

All fundamentals about Medcom Tech

Our stock analysis for Medcom Tech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medcom Tech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.